NS

Noorussabah Shabnam Begam

Active Director Director DIN 11402616
DIN 11402616 First appointment Nov 2025 Primary industry Consumer Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Noorussabah Shabnam Begam

Data last updated:

Noorussabah Shabnam Begam is a Director at Ziya India Medtour Private Limited (since 2025). The company operates in Consumer Services.

DIN 11402616
Primary Designation Director
Industry Consumer Services
First Appointment 30 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ziya India Medtour Private Limited U86900DL2025PTC458631
Director30 Nov 20252025Active

Board colleagues of Noorussabah Shabnam Begam

NameDINCompanyDesignation
Mohd Ekrama Zafar11402615Ziya India Medtour Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ziya India Medtour Private Limited
Premium access

Shareholding and investment profile for Noorussabah Shabnam Begam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Noorussabah Shabnam Begam

Noorussabah Shabnam Begam currently holds 1 directorship: Ziya India Medtour Private Limited (Director, since 30 Nov 2025).

Noorussabah Shabnam Begam was first appointed on 30 Nov 2025 as Director at Ziya India Medtour Private Limited.

The current boards of Noorussabah Shabnam Begam's companies include Mohd Ekrama Zafar (Ziya India Medtour Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available